ClinicalTrials.gg
CompletedNCT02239679Updated Aug 24, 2018Results posted

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

A Phase 2 interventional study of Aminolevulinic Acid and Topical Solution Vehicle in Actinic Keratosis, sponsored by DUSA Pharmaceuticals, Inc.. Completed at 8 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-08-24.

Sponsored by DUSA Pharmaceuticals, Inc. (part of Sun Pharmaceutical Industries Limited) · Phase 2, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
166
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 29 studies testing Aminolevulinic Acid in Keratosis, Actinic — 1 open to participants now, 2 under way, none of them phase 3. Aminolevulinic Acid · Keratosis, Actinic.

Enrollment
6th of 29
166 · median 32
Started
2014
with 3 others
Phase 2
11 of 29
none open now
Registered
9th of 29
by date
Lead sponsor
9 of 29
DUSA Pharmaceuticals, Inc.

Among the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic, this one is the 6th largest by enrollment, is one of 4 that started in 2014, is one of 11 in phase 2, and was the 9th registered.

Keratosis, Actinic

343 studies on the registry are indexed under Keratosis, Actinic; 29 are open to participants now.

Browse Keratosis, Actinic studies →

Open to participants now

1 of the 29 studies testing Aminolevulinic Acid in Keratosis, Actinic is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

About Aminolevulinic Acid

Aminolevulinic Acid: first FDA approval 1999 (LEVULAN), first EMA approval 2007. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 21 Keratosis, Actinic studies recruiting now, 16 (76%) set no upper age limit and 1 (5%) stops at 75 or younger; none take children under 18; 2 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 29 studies testing Aminolevulinic Acid in Keratosis, Actinic, or all of them as a file.
02

Study summary

The purpose of this study is to determine if Levulan photodynamic therapy (PDT) is safe and effective in the treatment of actinic keratoses (AK) on the face, following treatment with liquid nitrogen cryotherapy.

03

Conditions studied

  • Actinic Keratosis

Browse trials for

Keywords

  • Actinic Keratosis
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Four to fifteen AKs on the face
  • confirmed presence of abnormal architecture and satellite atypical keratinocytes in the epidermis, in clinically normal tissue samples of photodamaged skin adjacent to AKs
  • at least one previously treated nonmelanoma skin cancer (NMSC) on the head and/or neck area within the past five years

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • history of cutaneous photosensitization, porphyria, to porphyrins or photodermatosis
  • lesions suspicious for skin cancer (skin cancer not ruled out by ) or untreated skin cancers within the Treatment Area
  • skin pathology or condition which could interfere with the evaluation of the test product or requires the use of interfering topical or systemic therapy
  • Subject is
  • unsuccessful outcome from previous ALA-PDT therapy
  • currently enrolled in an drug or device study
  • has received an investigational drug or been treated with an investigational device within 30 days prior to the initiation of treatment
  • known sensitivity to one or more of the vehicle components (ethyl alcohol, isopropyl alcohol, laureth 4, polyethylene glycol)
  • has an active herpes simplex infection OR a history of 2 or more outbreaks within the past 12 months, on the face
  • use of the following topical preparations on the extremity to be treated:

    • Keratolytics including urea (greater than 5%), alpha hydroxyacids [e.g.glycolic acid, lactic acid, etc. greater than 5%], salicylic acid (greater than 2%) within 2 days
    • Retinoids, including tazarotene, adapalene, tretinoin, within 4 weeks
    • Microdermabrasion, laser ablative treatments, ALA-PDT, chemical peels, 5-fluorouracil (5-FU), diclofenac, ingenol mebutate, imiquimod or other topical treatments for AK within 8 weeks
  • use of systemic retinoid therapy within 6 months
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Histologically or cytologically confirmed

The diagnosis was confirmed by looking at a sample under a microscope: tissue from a biopsy or surgery (histology), or cells from a fluid or needle sample (cytology).

Your pathology report is the document that shows this.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
166 participants (actual)

Study arms

  • Experimental
    ALA X3

    Cryotherapy followed by 3 aminolevulinic acid + blue light (BLU-U) treatments

    Drug: Aminolevulinic Acid · Device: BLU-U · Procedure: Cryotherapy

  • Placebo comparator
    VEH

    Vehicle (VEH) group will be randomized (1:1) to be balanced for the two active groups; receiving cryotherapy and 2 or 3 subsequent Topical Solution Vehicle + BLU-U treatments. Subjects receiving VEH will be considered a single treatment group.

    Drug: Topical Solution Vehicle · Device: BLU-U · Procedure: Cryotherapy

  • Experimental
    ALA X2

    Cryotherapy followed by 2 aminolevulinic acid + BLU-U treatments

    Drug: Aminolevulinic Acid · Device: BLU-U · Procedure: Cryotherapy

Interventions

  • 20% ALA applied to face for one hour prior to 10 J/cm2 blue light

    Also known as: Levulan Kerastick, ALA

  • DrugTopical Solution Vehicle

    Levulan Kerastick containing vehicle ingredients only. Vehicle solution applied to face one hour prior to 10 J/cm2 blue light

  • DeviceBLU-U

    10 J/cm2 blue light delivered at 10 mW/cm2

    Also known as: BLU-U Blue Light Photodynamic Therapy Illuminator

  • ProcedureCryotherapy

    Liquid nitrogen cryotherapy by standard of care method to all visible/palpable actinic keratosis (AK) lesions at screening.

    Also known as: Liquid Nitrogen

06

What researchers measure

Primary outcomes

  1. Total Number of AKs in Treatment Area

    Count of observed lesions in the treatment area, which include lesions that recurred after on-study cryotherapy as well as newly occurring lesions. AK lesions in the treatment area at baseline (maximum of 2) were excluded for this endpoint.

    Time frame: Week 52

Secondary outcomes

  1. Proportion of Subjects With 0 AKs

    Normalized based on number of lesions present at Baseline

    Time frame: Week 4

  2. Subject Satisfaction Score

    Subject satisfaction score 1. = Excellent (very satisfied) 2. = Good (moderately satisfied) 3. = Fair (slightly satisfied) 4. = Poor (not satisfied at all) Unknown

    Time frame: Week 52

  3. Proportion of Subjects With 0 AKs

    Normalized based on number of lesions present at Baseline

    Time frame: Week 12

  4. Proportion of Subjects With 0 AKs

    Normalized based on number of lesions present at Baseline

    Time frame: Week 24

  5. Proportion of Subjects With 0 AKs

    Normalized based on number of lesions present at Baseline

    Time frame: Week 36

  6. Proportion of Subjects With 0 AKs

    Normalized based on number of lesions present at Baseline

    Time frame: Week 52

  7. Recurrence Rate

    Recurrence rate of all lesions that were complete responses following on-study cryotherapy (at Visit 3/Baseline).

    Time frame: Week 52

  8. Duration of Response

    Duration of response is the elapsed number of weeks from the Baseline visit until a lesion recurred or Week 52, whichever comes first

    Time frame: within 52 weeks after Baseline

Other outcomes

  1. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: Screening

  2. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: Baseline

  3. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 24-48 hours after photodynamic therapy (PDT) #1

  4. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 4 Weeks after PDT #1

  5. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 12 Weeks after PDT #1

  6. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 24 Weeks after PDT #1

  7. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 36 Weeks after PDT #1

  8. Hyperpigmentation

    HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

    Time frame: 52 Weeks after PDT #1

  9. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

    Time frame: Screening

  10. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

    Time frame: Baseline

  11. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

    Time frame: 24-48 hours after PDT #1

  12. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

    Time frame: 4 Weeks after PDT #1

  13. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

    Time frame: 12 Weeks after PDT #1

  14. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

    Time frame: 24 Weeks after PDT #1

  15. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

    Time frame: 36 Weeks after PDT #1

  16. Hypopigmentation

    HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

    Time frame: 52 Weeks after PDT #1

  17. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: Screening

  18. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: Baseline

  19. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 5 minutes after PDT #1

  20. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 24-48 hours after PDT #1

  21. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 4 Weeks after PDT #1

  22. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 12 Weeks after PDT #1

  23. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 24 Weeks after PDT #1

  24. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 36 Weeks after PDT #1

  25. Erythema

    Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

    Time frame: 52 Weeks after PDT #1

  26. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: Screening

  27. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: Baseline

  28. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 5 minutes after PDT #1

  29. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 24-48 hours after PDT #1

  30. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 4 Weeks after PDT #1

  31. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 12 Weeks after PDT #1

  32. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 24 weeks after PDT #1

  33. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 36 Weeks after PDT #1

  34. Edema

    EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

    Time frame: 52 Weeks after PDT #1

  35. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: Screening

  36. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: Baseline

  37. Stinging/Burning

    Immediately after PDT, the most intensive, acute perception of Stinging/Burning DURING treatment will be recorded. STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: During PDT #1

  38. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 5 minutes after PDT #1

  39. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 24-48 hours after PDT #1

  40. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 4 Weeks after PDT #1

  41. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 12 Weeks after PDT #1

  42. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 24 Weeks after PDT #1

  43. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 36 Weeks after PDT #1

  44. Stinging/Burning

    STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

    Time frame: 52 Weeks after PDT #1

  45. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: Screening

  46. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: Baseline

  47. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 24-48 hours after PDT #1

  48. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 4 Weeks after PDT #1

  49. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 12 Weeks after PDT #1

  50. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 24 Weeks after PDT #1

  51. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 36 Weeks after PDT #1

  52. Scaling & Dryness

    SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

    Time frame: 52 Weeks after PDT #1

  53. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: Screening

  54. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: Baseline

  55. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 24-48 hours after PDT #1

  56. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 4 Weeks after PDT #1

  57. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 12 Weeks after PDT #1

  58. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 24 Weeks after PDT #1

  59. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 36 Weeks after PDT #1

  60. Oozing/Vesiculation/Crusting

    OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

    Time frame: 52 Weeks after PDT #1

07

Results

Posted Sep 21, 2017

Participant flow

Participant flow — Overall Study
MilestoneALA X2ALA X3VEH-PDT
Started535954
Completed505653
Not completed331
Withdrew: Lost to follow-up100
Withdrew: Withdrawal by subject231

Outcome measures

PrimaryTotal Number of AKs in Treatment Area

Count of observed lesions in the treatment area, which include lesions that recurred after on-study cryotherapy as well as newly occurring lesions. AK lesions in the treatment area at baseline (maximum of 2) were excluded for this endpoint.

Time frame:
Week 52
Reported as:
Least squares mean · lesions
Total Number of AKs in Treatment Area
lesionsALA X2ALA X3VEH-PDT
Total Number of AKs in Treatment Area3.0 ± 0.912.1 ± 0.844.7 ± 0.86
Statistical analysis
  • ALA X3 vs VEH-PDT · ANCOVA · p = 0.0166
SecondaryProportion of Subjects With 0 AKs

Normalized based on number of lesions present at Baseline

Time frame:
Week 4
Reported as:
Count of participants · Participants
Proportion of Subjects With 0 AKs
ParticipantsALA X2ALA X3VEH-PDT
Proportion of Subjects With 0 AKs353527
SecondarySubject Satisfaction Score

Subject satisfaction score 1. = Excellent (very satisfied) 2. = Good (moderately satisfied) 3. = Fair (slightly satisfied) 4. = Poor (not satisfied at all) Unknown

Time frame:
Week 52
Reported as:
Count of participants · Participants
Subject Satisfaction Score
ParticipantsALA X2ALA X3VEH-PDT
Very Satisfied272616
Moderately Satisfied152114
Slightly Satisfied7914
Not Satisfied209
Unknown231
SecondaryProportion of Subjects With 0 AKs

Normalized based on number of lesions present at Baseline

Time frame:
Week 12
Reported as:
Count of participants · Participants
Proportion of Subjects With 0 AKs
ParticipantsALA X2ALA X3VEH-PDT
Proportion of Subjects With 0 AKs273522
SecondaryProportion of Subjects With 0 AKs

Normalized based on number of lesions present at Baseline

Time frame:
Week 24
Reported as:
Count of participants · Participants
Proportion of Subjects With 0 AKs
ParticipantsALA X2ALA X3VEH-PDT
Proportion of Subjects With 0 AKs302214
SecondaryProportion of Subjects With 0 AKs

Normalized based on number of lesions present at Baseline

Time frame:
Week 36
Reported as:
Count of participants · Participants
Proportion of Subjects With 0 AKs
ParticipantsALA X2ALA X3VEH-PDT
Proportion of Subjects With 0 AKs152010
SecondaryProportion of Subjects With 0 AKs

Normalized based on number of lesions present at Baseline

Time frame:
Week 52
Reported as:
Count of participants · Participants
Proportion of Subjects With 0 AKs
ParticipantsALA X2ALA X3VEH-PDT
Proportion of Subjects With 0 AKs182110
Statistical analysis
  • ALA X2 vs VEH-PDT · Cochran-Mantel-Haenszel · p = 0.0102 (no adjustments for multiple comparisons)stratified by site
  • ALA X3 vs VEH-PDT · Cochran-Mantel-Haenszel · p = 0.0089 (no adjustment for multiple comparisons)stratified by site
SecondaryRecurrence Rate

Recurrence rate of all lesions that were complete responses following on-study cryotherapy (at Visit 3/Baseline).

Time frame:
Week 52
Reported as:
Count of units · number of lesions
Recurrence Rate
number of lesionsALA X2ALA X3VEH-PDT
Recurrence Rate343281
Statistical analysis
  • ALA X2 vs VEH-PDT · Cochran-Mantel-Haenszel · p = 0.0004 (no adjustments for multiple comparisons)stratified by site
  • ALA X3 vs VEH-PDT · Cochran-Mantel-Haenszel · p = <0.0001 (no adjustment for multiple comparison)stratified by site
SecondaryDuration of Response

Duration of response is the elapsed number of weeks from the Baseline visit until a lesion recurred or Week 52, whichever comes first

Time frame:
within 52 weeks after Baseline
Reported as:
Mean · weeks
Duration of Response
weeksALA X2ALA X3VEH-PDT
Duration of Response35.9 ± 20.433.3 ± 19.725.9 ± 20.7
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
Screening
Reported as:
Count of participants · Participants
Hyperpigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0222725
Grade 1172320
Grade 21358
Grade 3131
Grade 4010
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
Baseline
Reported as:
Count of participants · Participants
Hyperpigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0232622
Grade 1172522
Grade 21259
Grade 3121
Grade 4010
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
24-48 hours after photodynamic therapy (PDT) #1
Reported as:
Count of participants · Participants
Hyperpigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0232223
Grade 1142421
Grade 213108
Grade 3301
Grade 4010
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
4 Weeks after PDT #1
Reported as:
Count of participants · Participants
Hyperpigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0212623
Grade 1212523
Grade 2847
Grade 3111
Grade 4010
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
12 Weeks after PDT #1
Reported as:
Count of participants · Participants
Hyperpigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0222823
Grade 1212223
Grade 2856
Grade 3011
Grade 4010
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
24 Weeks after PDT #1
Reported as:
Count of participants · Participants
Hyperpigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0252624
Grade 1182423
Grade 2845
Grade 3011
Grade 4010
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
36 Weeks after PDT #1
Reported as:
Count of participants · Participants
Hyperpigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0242524
Grade 1192623
Grade 2735
Grade 3011
Grade 4010
Other pre-specifiedHyperpigmentation

HYPERPIGMENTATION SCALE Grade 0 = No hyperpigmentation Grade 1 = Light hyperpigmentation involving small areas Grade 2 = Moderate hyperpigmentation involving small areas; light hyperpigmentation involving moderate areas Grade 3 = Moderate hyperpigmentation involving moderate sized areas; light hyperpigmentation involving large areas; small areas of marked hyperpigmentation Grade 4 = Marked hyperpigmentation involving moderate or large sized areas

Time frame:
52 Weeks after PDT #1
Reported as:
Count of participants · Participants
Hyperpigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0222424
Grade 1212523
Grade 2755
Grade 3011
Grade 4010
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

Time frame:
Screening
Reported as:
Count of participants · Participants
Hypopigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0354038
Grade 1161714
Grade 2222
Grade 3000
Grade 4000
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

Time frame:
Baseline
Reported as:
Count of participants · Participants
Hypopigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0373837
Grade 1141914
Grade 2223
Grade 3000
Grade 4000
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

Time frame:
24-48 hours after PDT #1
Reported as:
Count of participants · Participants
Hypopigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0343535
Grade 1141916
Grade 2422
Grade 3110
Grade 4000
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

Time frame:
4 Weeks after PDT #1
Reported as:
Count of participants · Participants
Hypopigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0343835
Grade 1141717
Grade 2322
Grade 3000
Grade 4000
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

Time frame:
12 Weeks after PDT #1
Reported as:
Count of participants · Participants
Hypopigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0334035
Grade 1141517
Grade 2411
Grade 3010
Grade 4000
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

Time frame:
24 Weeks after PDT #1
Reported as:
Count of participants · Participants
Hypopigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0333937
Grade 1161515
Grade 2211
Grade 3010
Grade 4000
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

Time frame:
36 Weeks after PDT #1
Reported as:
Count of participants · Participants
Hypopigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0313835
Grade 1181617
Grade 2111
Grade 3010
Grade 4000
Other pre-specifiedHypopigmentation

HYPOPIGMENTATION SCALE Grade 0 = No hypopigmentation Grade 1 = Light hypopigmentation involving small areas Grade 2 = Moderate hypopigmentation involving small areas; light hypopigmentation involving moderate areas Grade 3 = Moderate hypopigmentation involving moderate sized areas; light hypopigmentation involving large areas; small areas of marked hypopigmentation

Time frame:
52 Weeks after PDT #1
Reported as:
Count of participants · Participants
Hypopigmentation
ParticipantsALA X2ALA X3VEH-PDT
Grade 0263533
Grade 1221919
Grade 2211
Grade 3010
Grade 4000
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
Screening
Reported as:
Count of participants · Participants
Erythema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0314133
Grade 1161313
Grade 2648
Grade 3010
Grade 4000
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
Baseline
Reported as:
Count of participants · Participants
Erythema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0343833
Grade 1141815
Grade 2536
Grade 3000
Grade 4000
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
5 minutes after PDT #1
Reported as:
Count of participants · Participants
Erythema
ParticipantsALA X2ALA X3VEH-PDT
Grade 04611
Grade 181127
Grade 2292512
Grade 312174
Grade 4000
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
24-48 hours after PDT #1
Reported as:
Count of participants · Participants
Erythema
ParticipantsALA X2ALA X3VEH-PDT
Grade 02322
Grade 1121021
Grade 213148
Grade 323262
Grade 4340
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
4 Weeks after PDT #1
Reported as:
Count of participants · Participants
Erythema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0354134
Grade 1141415
Grade 2225
Grade 3000
Grade 4000
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
12 Weeks after PDT #1
Reported as:
Count of participants · Participants
Erythema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0354336
Grade 1161315
Grade 2011
Grade 3001
Grade 4000
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
24 Weeks after PDT #1
Reported as:
Count of participants · Participants
Erythema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0374131
Grade 1141320
Grade 2022
Grade 3000
Grade 4000
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
36 Weeks after PDT #1
Reported as:
Count of participants · Participants
Erythema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0373633
Grade 1131918
Grade 2012
Grade 3000
Grade 4000
Other pre-specifiedErythema

Erythema Scale - Grade 0 = None Grade 1 = Minimal - barely perceptible erythema Grade 2 = Mild - predominantly minimal erythema (pink) in the treated area with or without a few isolated areas of more intense erythema Grade 3 = Moderate - predominantly moderate erythema (red) in the treated area with or without a few isolated areas of intense erythema (bright red) Grade 4 = Severe - predominantly intense erythema (bright red) in the treated area with or without a few isolated areas of very intense (fiery red) erythema

Time frame:
52 Weeks after PDT #1
Reported as:
Count of participants · Participants
Erythema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0384037
Grade 1111414
Grade 2122
Grade 3000
Grade 4000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
Screening
Reported as:
Count of participants · Participants
Edema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0525954
Grade 1100
Grade 2000
Grade 3000
Grade 4000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
Baseline
Reported as:
Count of participants · Participants
Edema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0535954
Grade 1000
Grade 2000
Grade 3000
Grade 4000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
5 minutes after PDT #1
Reported as:
Count of participants · Participants
Edema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0464452
Grade 16122
Grade 2120
Grade 3010
Grade 4000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
24-48 hours after PDT #1
Reported as:
Count of participants · Participants
Edema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0333153
Grade 114160
Grade 26100
Grade 3000
Grade 4000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
4 Weeks after PDT #1
Reported as:
Count of participants · Participants
Edema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0515653
Grade 1001
Grade 2010
Grade 3000
Grade 4000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
12 Weeks after PDT #1
Reported as:
Count of participants · Participants
Edema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0515753
Grade 1000
Grade 2000
Grade 3000
Grade 4000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
24 weeks after PDT #1
Reported as:
Count of participants · Participants
Edema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0515653
Grade 1000
Grade 2000
Grade 3000
Grade 4000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
36 Weeks after PDT #1
Reported as:
Count of participants · Participants
Edema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0495551
Grade 1111
Grade 2001
Grade 3000
Grade 4000
Other pre-specifiedEdema

EDEMA SCALE Grade 0 = None Grade 1 = Minimal - scant, rare edema Grade 2 = Mild - easily seen edema, minimally palpable, involving up to 1/3 of the treatment area Grade 3 = Moderate - easily seen edema and typically palpable, involving between 1/3 to 2/3 of the treatment area Grade 4 = Severe - easily seen edema, indurated in some areas, involving over 2/3 of the treatment area

Time frame:
52 Weeks after PDT #1
Reported as:
Count of participants · Participants
Edema
ParticipantsALA X2ALA X3VEH-PDT
Grade 0505653
Grade 1000
Grade 2000
Grade 3000
Grade 4000
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
Screening
Reported as:
Count of participants · Participants
Stinging/Burning
ParticipantsALA X2ALA X3VEH-PDT
Grade 0535853
Grade 1011
Grade 2000
Grade 3000
Grade 4000
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
Baseline
Reported as:
Count of participants · Participants
Stinging/Burning
ParticipantsALA X2ALA X3VEH-PDT
Grade 0535953
Grade 1001
Grade 2000
Grade 3000
Grade 4000
Other pre-specifiedStinging/Burning

Immediately after PDT, the most intensive, acute perception of Stinging/Burning DURING treatment will be recorded. STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
During PDT #1
Reported as:
Count of participants · Participants
Stinging/Burning
ParticipantsALA X2ALA X3VEH-PDT
Grade 05542
Grade 1182111
Grade 227321
Grade 3310
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
5 minutes after PDT #1
Reported as:
Count of participants · Participants
Stinging/Burning
ParticipantsALA X2ALA X3VEH-PDT
Grade 0111146
Grade 133378
Grade 29110
Grade 3000
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
24-48 hours after PDT #1
Reported as:
Count of participants · Participants
Stinging/Burning
ParticipantsALA X2ALA X3VEH-PDT
Grade 0312351
Grade 117292
Grade 2550
Grade 3000
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
4 Weeks after PDT #1
Reported as:
Count of participants · Participants
Stinging/Burning
ParticipantsALA X2ALA X3VEH-PDT
Grade 0515753
Grade 1000
Grade 2001
Grade 3000
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
12 Weeks after PDT #1
Reported as:
Count of participants · Participants
Stinging/Burning
ParticipantsALA X2ALA X3VEH-PDT
Grade 0515752
Grade 1001
Grade 2000
Grade 3000
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
24 Weeks after PDT #1
Reported as:
Count of participants · Participants
Stinging/Burning
ParticipantsALA X2ALA X3VEH-PDT
Grade 0515553
Grade 1010
Grade 2000
Grade 3000
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
36 Weeks after PDT #1
Reported as:
Count of participants · Participants
Stinging/Burning
ParticipantsALA X2ALA X3VEH-PDT
Grade 0495651
Grade 1002
Grade 2100
Grade 3000
Other pre-specifiedStinging/Burning

STINGING AND BURNING SCALE Grade 0 = None Grade 1 = Minimal, barely perceptible -tolerable and little discomfort Grade 2 = Moderate - tolerable, but causes some discomfort Grade 3 = Severe - very uncomfortable or intolerable

Time frame:
52 Weeks after PDT #1
Reported as:
Count of participants · Participants
Stinging/Burning
ParticipantsALA X2ALA X3VEH-PDT
Grade 0495652
Grade 1100
Grade 2001
Grade 3000
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
Screening
Reported as:
Count of participants · Participants
Scaling & Dryness
ParticipantsALA X2ALA X3VEH-PDT
Grade 0414340
Grade 181111
Grade 2443
Grade 3010
Grade 4000
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
Baseline
Reported as:
Count of participants · Participants
Scaling & Dryness
ParticipantsALA X2ALA X3VEH-PDT
Grade 0384439
Grade 1101211
Grade 2434
Grade 3100
Grade 4000
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
24-48 hours after PDT #1
Reported as:
Count of participants · Participants
Scaling & Dryness
ParticipantsALA X2ALA X3VEH-PDT
Grade 0303538
Grade 1181413
Grade 2472
Grade 3110
Grade 4000
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
4 Weeks after PDT #1
Reported as:
Count of participants · Participants
Scaling & Dryness
ParticipantsALA X2ALA X3VEH-PDT
Grade 0414641
Grade 1101011
Grade 2012
Grade 3000
Grade 4000
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
12 Weeks after PDT #1
Reported as:
Count of participants · Participants
Scaling & Dryness
ParticipantsALA X2ALA X3VEH-PDT
Grade 0404443
Grade 110117
Grade 2022
Grade 3101
Grade 4000
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
24 Weeks after PDT #1
Reported as:
Count of participants · Participants
Scaling & Dryness
ParticipantsALA X2ALA X3VEH-PDT
Grade 0434639
Grade 16812
Grade 2222
Grade 3000
Grade 4000
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
36 Weeks after PDT #1
Reported as:
Count of participants · Participants
Scaling & Dryness
ParticipantsALA X2ALA X3VEH-PDT
Grade 0384638
Grade 111813
Grade 2122
Grade 3000
Grade 4000
Other pre-specifiedScaling & Dryness

SCALING AND DRYNESS SCALE Grade 0 = None Grade 1 = Minimal - barely perceptible desquamation Grade 2 = Mild - limited areas of fine desquamation in up to 1/3 of the treatment area Grade 3 = Moderate - fine desquamation involving 1/3 to 2/3 of the treatment area or limited areas of coarser scaling Grade 4 = Severe - coarser scaling involving more than 2/3 of the treatment area or limited areas of very coarse scaling

Time frame:
52 Weeks after PDT #1
Reported as:
Count of participants · Participants
Scaling & Dryness
ParticipantsALA X2ALA X3VEH-PDT
Grade 0424247
Grade 16104
Grade 2242
Grade 3000
Grade 4000
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
Screening
Reported as:
Count of participants · Participants
Oozing/Vesiculation/Crusting
ParticipantsALA X2ALA X3VEH-PDT
Grade 0535853
Grade 1011
Grade 2000
Grade 3000
Grade 4000
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
Baseline
Reported as:
Count of participants · Participants
Oozing/Vesiculation/Crusting
ParticipantsALA X2ALA X3VEH-PDT
Grade 0495851
Grade 1412
Grade 2001
Grade 3000
Grade 4000
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
24-48 hours after PDT #1
Reported as:
Count of participants · Participants
Oozing/Vesiculation/Crusting
ParticipantsALA X2ALA X3VEH-PDT
Grade 0505349
Grade 1333
Grade 2001
Grade 3010
Grade 4000
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
4 Weeks after PDT #1
Reported as:
Count of participants · Participants
Oozing/Vesiculation/Crusting
ParticipantsALA X2ALA X3VEH-PDT
Grade 0515651
Grade 1012
Grade 2001
Grade 3000
Grade 4000
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
12 Weeks after PDT #1
Reported as:
Count of participants · Participants
Oozing/Vesiculation/Crusting
ParticipantsALA X2ALA X3VEH-PDT
Grade 0505653
Grade 1110
Grade 2000
Grade 3000
Grade 4000
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
24 Weeks after PDT #1
Reported as:
Count of participants · Participants
Oozing/Vesiculation/Crusting
ParticipantsALA X2ALA X3VEH-PDT
Grade 0505653
Grade 1100
Grade 2000
Grade 3000
Grade 4000
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
36 Weeks after PDT #1
Reported as:
Count of participants · Participants
Oozing/Vesiculation/Crusting
ParticipantsALA X2ALA X3VEH-PDT
Grade 0505652
Grade 1001
Grade 2000
Grade 3000
Grade 4000
Other pre-specifiedOozing/Vesiculation/Crusting

OOZING/VESICULATION/CRUSTING Grade 0 = None Grade 1 = Minimal - a single area of oozing, vesiculation or crusting 3 mm diameter or less in size Grade 2 = Mild - two to four areas of oozing, vesiculation or crusting 3 mm diameter or less in size OR a single area larger than 3 mm diameter in size Grade 3 = Moderate - more than a single area of oozing, vesiculation or crusting larger than 3 mm diameter in size or more than four areas of 3 mm diameter or less in size Grade 4 = Severe - any degree of oozing, vesiculation or crusting greater than (3) above

Time frame:
52 Weeks after PDT #1
Reported as:
Count of participants · Participants
Oozing/Vesiculation/Crusting
ParticipantsALA X2ALA X3VEH-PDT
Grade 0495653
Grade 1100
Grade 2000
Grade 3000
Grade 4000

Adverse events

Collected over 52 weeks. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
ALA X20/53 (0%)0/53 (0%)13/53 (24.5%)
ALA X30/59 (0%)3/59 (5.1%)9/59 (15.3%)
VEH-PDT0/54 (0%)4/54 (7.4%)15/54 (27.8%)
Most frequent serious events
Most frequent serious events
EventALA X2ALA X3VEH-PDT
acute myocardial infarctionCardiac disorders0/530/591/54
atrial fibrillationCardiac disorders0/530/591/54
coronary artery diseaseCardiac disorders0/530/591/54
upper gastrointestinal haemorrhageGastrointestinal disorders0/530/591/54
duodenal neoplasmNeoplasms benign, malignant and unspecified (incl cysts and polyps)0/530/591/54
angina unstableCardiac disorders0/531/590/54
vertigoEar and labyrinth disorders0/531/590/54
headacheNervous system disorders0/531/590/54
Most frequent other events
Most frequent other events
EventALA X2ALA X3VEH-PDT
basal cell carcinomaNeoplasms benign, malignant and unspecified (incl cysts and polyps)9/535/594/54
squamous cell carcinoma of skinNeoplasms benign, malignant and unspecified (incl cysts and polyps)6/533/598/54
squamous cell carcinomaNeoplasms benign, malignant and unspecified (incl cysts and polyps)3/531/590/54
procedural painInjury, poisoning and procedural complications0/531/593/54
back painMusculoskeletal and connective tissue disorders0/530/593/54

Baseline characteristics

Age, Continuous
Age, Continuous(years)ALA X2ALA X3VEH-PDTTotal
Mean67.9 ± 9.6566.7 ± 9.3565.8 ± 9.566.8 ± 9.48
Sex: Female, Male
Sex: Female, Male(Participants)ALA X2ALA X3VEH-PDTTotal
Female10111031
Male434844135
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)ALA X2ALA X3VEH-PDTTotal
Hispanic or Latino1012
Not Hispanic or Latino525953164
Unknown or Not Reported0000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)ALA X2ALA X3VEH-PDTTotal
American Indian or Alaska Native0000
Asian0000
Native Hawaiian or Other Pacific Islander0000
Black or African American0000
White535954166
More than one race0000
Unknown or Not Reported0000
Region of Enrollment
Region of Enrollment(Participants)ALA X2ALA X3VEH-PDTTotal
United States535954166
Skin Type
Skin Type(Participants)ALA X2ALA X3VEH-PDTTotal
Skin Type I - Burns easily, never tans65213
Skin Type II - Burns easily, tans minimally293735101
Skin Type III - Burns moderately, tans gradually16121240
Skin Type IV - Burns minimally, tans well24511
Skin Type V - Rarely burns, tans profusely0101
08

Study locations

8 sites
  • UCSD Dermatology
    San Diego, California 92122, United States
  • Therapeutics Clinical Research
    San Diego, California 92123, United States
  • Altman Dermatology Associates
    Arlington Heights, Illinois 60005, United States
  • Shideler Clinical Research Center
    Carmel, Indiana 46032, United States
  • Sadick Research Group
    New York, New York 10075, United States
  • Tennessee Clinical Research Center
    Nashville, Tennessee 37215, United States
  • Suzanne Bruce and Associates, P.A.,The Center for Skin Research
    Houston, Texas 77056, United States
  • Virginia Clinical Research, Inc.
    Norfolk, Virginia 23507, United States
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Sep 2014, a primary completion of Jul 2016 and a completion of Sep 2016. It does not say whether these dates are actual or estimated.

Results were first posted in Sep 2017, 1 year 2 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 10, 2014
First posted
Sep 15, 2014
Start
Sep 2014
Primary completionActual
Jul 2016
CompletionActual
Sep 2016
Results first posted
Sep 21, 2017
Last update
Aug 24, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 24, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02239679
Responsible party
Sponsor
First posted
Sep 15, 2014
Start date
Sep 2014
Primary completion
Jul 2016
Completion
Sep 2016
Results posted
Sep 21, 2017
Last update
Aug 24, 2018

Study contacts

Stuart Marcus, MD, PhD
study director · DUSA Pharmaceuticals, Inc.

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Aminolevulinic Acid

Start the discussion